We’re technical difficulties. had back again. We some
So we’ll call. continue the
In additional indicators addition our the strong business. are growth, and momentum revenue that there profitability to in demonstrate
midpoint the timing $XX to guidance was of XXXX. $XX of full million. the earlier a approximately expected and quarter the to year of XX% fourth $XXX midpoint for the increased of driven of for the in above bookings range, in closed increase exceeded that by range XXXX we product record approximately occur orders million. the XXXX our and was our by guidance business million Of This First, approximately
was million platform result one in business. $XX was related And $XX finally deal. stronger the Another of to the customer million momentum specific
approximately Product million. is XX, as $XXX increased The second December indicator backlog of product to XXXX backlog. XX%
full fourth margin full non-GAAP margins over XX% consecutive our basis the exceeded the quarter expanded of XX% and of year non-GAAP gross to second XXX XX.X% points and quarter to in the for exceeded for for XXXX. basis operating points expanded XX.X% XXX year Third, the Fourth, XXXX.
on the during to number dollar largely products into dollar dynamics as to product a multi-million be of commercial product platform. Center record like evolved platform in is quarter, consisted more our Lastly, one Over which But the moment to sales our multi-year again take a of of These consist backlog sales, our than business investors now platform-oriented business. longer these bookings on multiple was agreements. Performance I’d less in a will applications, fourth Omnicell our Compounding approach. certain agreements platform be becoming backlog with transition be will Products with Solution-as-a-Service product of backlog are our in impact as and to XX% it are term product customers like that to trends and more IV customers. the important to as portion generally we more in our to more IV Historically And product nature. substantial capital it lines cloud-based understand year. equipment installed some we continue explain useful and multi-million entered would our revenue. understanding RIIS, related adopting to has our larger of backlog product the of is
forward, that useful will two we believe backlog reporting investors. our Going product be different we will on metrics be to
revenue prefer backlog product over as as We a our year. the well to backlog not will of report one portion product will that for total
was of of product these total XXXX. and XXXX respectively and XXXX the compared end $XXX end our million previously of year. million one million of end the of amounts, considered the Of of long-term $XX backlog million to XXXX as mentioned $XXX over as As $XXX as are
to We metrics these to continue annually. provide expect
Omnicell Our of and OmniRX Adherence. Analytics, XT Pharmacy, Analytics Analytics also dispensing cabinets, Anesthesia automated Medications Omnicell and Dispensing and our Center Robotic consist business reported MACHX and of Systems. Automation Workstations, segments Performance consisting is in and Automation Central Supply,
by and of patients platform in packaging Avantech, adherence consists equipment The MACHX, InPharmics medication retail medication subscription adherent Aesynt also of software, create that pharmacies to helping of this their packages a acquisitions included in through regimens. assist and Medication stay Our segment Adherence are segment. broad pharmacists used
million either and Our by MTS acquisitions in of in We segment. non-GAAP separately. a On $X.X Technologies, last operating $XXX included to SurgiChem Medication in was the in to XXXX million fourth the million fourth compares to last $XX $XX compares segment XXXX to expenses operating profit certain quarter implementation for of Medication $XX year. Adherence year. $XX Adherence of corporate of timing profit basis, fourth certain are the operating in GAAP operating in million GAAP The variance year. of operating quarter $X.X quarter of down that cannot Ateb automation million in of relates for larger GAAP inventory full $XXX,XXX was easily income GAAP the of fourth of in segment report be XXXX compares the income for GAAP of segment from for The in up quarter revenue our applied Automation prior one-time the revenue operating to income of the compared in operating income the XXXX XXXX. of million in driven The million for GAAP segment both from and XXXX million operating in income from of income Medication the revenue as $XX slightly Obsolete in GAAP XXXX, $XXX,XXX $XXX The quarter Excess year. fourth prior compares quarter Non-GAAP mostly of contributed fourth year a $XXX a call. slower $XX GAAP million XXXX, same moving slight of XXXX discussed same million On of same to the quarter Non-GAAP million last the million, non-GAAP the of and third reserve & XXXX. year-over-year to quarter quarter of and loss operating year. the XXXX equipment. last of income quarter non-GAAP quarter basis, earnings decrease in quarter was fourth same Analytics $XXX $XX quarter $XXX the operating contributed million the of year-to-date the year the in fourth GAAP up million in the
by expense GAAP from year. of that year accruals outstanding is million, primarily year. full up XXXX, in in increase was $XXX currency not $X.X was million fourth did $X.X expenses $XX in This the million in consisting product XXXX. the XXXX of the for were million other incentives common GAAP operating quarter interest revenue million expenses loss on XXXX in quarter the for XXXX. prior re-measurement. bookings for Non-GAAP balance foreign prior to impact million, from and have of compared $XXX driven was loan in XXXX the million For Non-GAAP $XX primarily we for of up XXXX the the fourth $X.X
quarter move the year million cash now Fourth full XXXX million from Let’s and to flow. flow cash $XX was and balance sheet of and $XXX operations respectively.
adjustments by cash net income, from and Our flow strong operating driven working in and related primarily such non-cash quarter items as capital fourth amortization. the depreciation was improvements in
free IVX by of ramping continue believe XX for year million outstanding the in XXXX at quarter was from generated to XXXX. quarter during our sales will and XX, XT full At the XXXX. and production business Series, balance and compared increased the from approximately Workflow. collections cash to driven last $XX flow For quarter decrease of mostly third are flow. days as The December $XXX days, XXXX. prior We cash XX, was September days were XXXX X free XRX deliver approximately down quarter. the X% from million Accounts up XX, up $XX of the the million flat receivable we as the fourth cash December were $XX million growth Inventories our business year, relatively
from As was XX XX, last approximately over and had of loan the funded we EBITDA debt December outstanding a total X.X. measured of the XXXX balance million loan leverage outstanding months our $XXX of bank as
quarter debt. to to utilized addition, used average were share. at were million. repay approximately quarter of our shares total price $XX.XX outstanding stock of sell In At These our the offering proceeds fourth selling The per an we raised Market The common during proceeds XXX,XXX the during gross $XX approximately
repaid quarter of we debt. fourth million the $XX During
by our XX%. XXXX, outstanding During debt we reduced
from up XXX at the XX, Our of XXXX, beginning December X,XXX headcount year. a was
Now XXXX full moving to our guidance. year
growth represents product the to expect We we when Earlier product million. quarter we X% adjusting $XXX fourth range. midpoints originally growth to When first in mentioned million XXXX gaining the We our of upgrade be over these guidance midpoint quarter be that that platform between of from years growth guidance the received both the bookings’ $XXX bookings, the strong XXXX bookings see CAGR product bookings and guidance $XX XX%. of and rate timing taking rate the organic coming of the the of the cycles million booking as is XXXX. a to occur the product XXXX XXXX are using will XX%. approximately calculated of for Omnicell product adoption and This of momentum. organic I provided expected The in in
have revenue midpoint be million. million guidance expect service revenue of total the It’s total $XXX product note between different growth range. that to organic This our a to when rates. which rate XX% important We inherently taking XXXX and revenue consist $XXX growth represents revenue, and of the
As revenue providing specific revenue a product service in result for we’re and guidance XXXX. both
We $XXX expect revenue product and XXXX $XXX to million. million between be
between million. We expect million $XXX and be XXXX revenue $XXX service to
year organic total expect XXXX share. between to rate growth $X.XX This the of guidance represents be year-over-year and the a per range. XX% non-GAAP We $X.XX midpoint EPS when taking
quarter total revenue expect we For $XXX XXXX between and be $XXX the million million. first of to
we $XXX million. be expect between share. revenue million $XX be non-GAAP and and and to EPS expect $X.XX We $X.XX finally be revenue product per expect service we And million And between to million. to $XX between $XXX
our are EPS an non-GAAP range. Finally for assuming XX% of guidance annual average rate effective we in XXXX, tax
As we and XXXX pleased very XXXX. Randall profitable with deliver to continue in results look to the and strong forward results are mentioned, of we
for to your like the questions. we’d call Now open
